查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600661

连续肾臟替代疗法市场：按产品、方式、年龄层、适应症和最终用户 - 2025-2030 年全球预测

Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年持续肾臟替代治疗市值为142.8亿美元，预计到2024年将达到154.9亿美元，复合年增长率为8.55%，到2030年将达到253.7亿美元。

连续性肾臟替代疗法 (CRRT) 是一种用于支持急性肾衰竭患者的医疗程序，主要在加护病房进行。 CRRT 在 24 小时内持续净化血液，清除废物和多余液体，同时保持电解质平衡。 CRRT 的需求出现在无法耐受传统血液透析机的重症患者中，对于败血症和多重器官衰竭等病理状况至关重要。 CRRT 应用涵盖各种医疗保健环境，但主要用于医院、重症监护室和专科诊所。最终用途范围主要包括拥有加护治疗设施的医院，随着医疗基础设施的改善，新兴国家的需求可能会增加。

主要市场统计
基准年[2023] 142.8亿美元
预测年份 [2024] 154.9亿美元
预测年份 [2030] 253.7亿美元
复合年增长率（%） 8.55%

急性肾衰竭发生率的增加、CRRT 技术的进步以及糖尿病等慢性病盛行率的上升是主要的市场成长要素。医疗保健支出的增加和政府对先进医学的倡议进一步推动了市场扩张。然而，高昂的营运成本、对熟练人员的需求以及感染疾病等併发症的风险给市场成长带来了挑战。为医疗保健专业人员开发具有成本效益的 CRRT 设备和全面的培训计划可以鼓励更广泛的采用并解决技能差距。

研究和创新领域包括提高 CRRT 设备的效率、整合人工智慧进行即时资料监测以优化患者治疗结果，以及探索可携式CRRT 设备的更广泛应用。对更有效率的生物相容性材料和自动化 CRRT 系统的研究正在取得进展，市场有望显着成长。公司可以透过投资扩充性的技术解决方案并与医疗保健提供者合作提供客製化解决方案来提高市场渗透率。虽然商业机会比比皆是，但保持监管合规性和关注病人安全至关重要。总而言之，这些因素显示 CRRT 市场竞争激烈且复杂，但透过策略创新和适应有许多成长途径。

市场动态：揭示快速发展的连续肾臟替代治疗市场的关键市场洞察

供需的动态交互作用正在改变持续的肾臟替代治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 急性肾损伤（AKI）和慢性肾臟病（CKD）的增加
    • 为儿科和新生儿患者提供改良的 CCRT 系统
  • 市场限制因素
    • 连续性肾臟替代治疗程序的高成本
  • 市场机会
    • 持续研发以提高 CRRT 的安全性和有效性
    • CRRT 设备和技术获得政府有利核准
  • 市场挑战
    • 与连续性肾臟替代治疗相关的技术性併发症

波特五力：引领持续肾臟替代疗法市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解持续性肾臟替代治疗市场的外部影响

外部宏观环境因素在塑造连续性肾臟替代治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解连续性肾臟替代治疗市场的竞争格局

对连续性肾臟替代治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵连续性肾臟替代疗法市场供应商的绩效评估

FPNV 定位矩阵是评估连续性肾臟替代疗法市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 急性肾损伤（AKI）和慢性肾臟病（CKD）的发生率上升
      • 为儿科和新生儿患者提供改良的 CCRT 系统
    • 抑制因素
      • 连续性肾臟替代治疗程序的高成本
    • 机会
      • 持续研发以提高 CRRT 的安全性和有效性
      • CRRT 设备和技术获得政府有利核准
    • 任务
      • 与连续性肾臟替代治疗相关的技术问题
  • 市场区隔分析
    • 产品：急性肾损伤 (AKI) 盛行率的不断上升增加了对 CRRT 设备进行无缝治疗程序的需求。
    • 方法：利用连续性静脉血液滤过透析进行肾臟治疗中的自由水管理
    • 年龄层：儿科族群 CRRT 要求的差异
    • 适应症：在体外肾臟治疗中越来越多地采用非肾臟适应症
    • 最终用户：增加医院中 CRRT 设备的使用以满足病患需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章连续肾臟替代治疗市场：副产品

  • CRRT系统
  • 透析液和置换液
  • 一次性的
    • 身体线组和管子
    • 血液过滤器

第七章连续肾臟替代治疗市场：按方式

  • 连续性静脉血液滤过透析
  • 连续性静脉血液血液透析机
  • 连续性静脉血液滤过
  • 低速连续超过滤

第八章连续肾臟替代治疗市场：依年龄组

  • 成人
  • 小儿科

第九章连续肾臟替代治疗市场（按适应症）

  • 非肾
  • 肾

第10章连续肾臟替代治疗市场：依最终用户分类

  • 透析诊所
  • 居家护理
  • 医院

第十一章美洲连续肾臟替代治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区持续肾臟替代治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲连续性肾臟替代治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • B. Braun 的 AQUAbase nX逆渗透系统已获得 FDA 许可
    • Quanta 获得 FDA 510(k)核准，扩大连续性肾臟替代治疗的适应症
    • Rockwell Medical 宣布与 B. Brown Medical 建立为期三年的共同促销合作伙伴关係
    • Nuwellis 和 DaVita 合作开展超过滤治疗试验计画
    • Baxter 和 Miromatrix 合作研究肝功能衰竭
    • PBMC 为透析患者推出新的肾臟治疗方案
    • Sea Star Medical 与 Nuweris 合作治疗肾臟损伤
    • Spectral Medical 宣布与 Infomed 成立策略合资企业，以加速 DIMI 和 SAMI透析设备的商业化。
    • 百特宣布美国FDA核准ST 装置用于治疗医院急性肾衰竭患者

公司名单

  • Joline GmbH & Co. KG
  • Infomed SA
  • Anjue Medical Equipment Co., Ltd.
  • Medites Pharma spol. sro
  • Baxter International Inc.
  • SB-KAWASUMI LABORATORIES, INC.
  • Shionogi & Company, Limited
  • B. Braun SE
  • Medtronic PLC
  • Thermo Fisher Scientific Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • DIAMED Medizintechnik GmbH
  • Biomedica Medizinprodukte GmbH
  • Nextkidney BV
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corporation
  • Ningbo Tianyi Medical Devices Co., Ltd.
  • Braun & Co. Limited
  • Quanta Dialysis Technologies Limited
  • Miromatrix Medical Inc.
  • Sphingotec GmbH
  • CytoSorbents Corporation
  • Toray Medical Co., Ltd. by Toray Industries, Inc.
  • Nuwellis, Inc.
  • SWS Hemodialysis Care Co. Ltd.
  • Nikkiso Co., Ltd.
Product Code: MRR-433AB1DC293A

The Continuous Renal Replacement Therapy Market was valued at USD 14.28 billion in 2023, expected to reach USD 15.49 billion in 2024, and is projected to grow at a CAGR of 8.55%, to USD 25.37 billion by 2030.

Continuous Renal Replacement Therapy (CRRT) is a medical procedure used primarily in intensive care units to support patients with acute kidney injury. The procedure continuously purifies the blood over 24 hours, removing waste products and excess fluid while maintaining electrolyte balance. The necessity of CRRT arises in critically ill patients unable to tolerate conventional hemodialysis, making it essential for conditions such as sepsis and multiple organ failures. Its application extends across various medical settings but is predominantly utilized in hospitals, critical care units, and specialty clinics. The end-use scope primarily involves hospitals equipped with intensive care facilities, with potential demand increase in developing countries as medical infrastructures improve.

KEY MARKET STATISTICS
Base Year [2023] USD 14.28 billion
Estimated Year [2024] USD 15.49 billion
Forecast Year [2030] USD 25.37 billion
CAGR (%) 8.55%

Growing incidences of acute kidney failure, advances in CRRT technology, and the rising prevalence of chronic conditions like diabetes are key market growth factors. Market expansion is further propelled by increased healthcare spending and government initiatives towards advanced medical procedures. However, high operational costs, the requirement for skilled personnel, and risk of complications such as infections challenge market growth. An opportunity lies in developing cost-effective CRRT machines and comprehensive training programs for healthcare providers, which can encourage wider adoption and address skill gap issues.

Research and innovation areas include enhancing the efficiency of CRRT machines, integrating AI for real-time data monitoring to optimize patient outcomes, and exploring portable CRRT devices for wider application. The market is poised for significant growth with ongoing research into more efficient biocompatible materials and automated CRRT systems. For businesses, investing in scalable technology solutions and collaborating with healthcare providers for customized solutions could enhance market penetration. While opportunities abound, maintaining regulatory compliance and focusing on patient safety are indispensable. These elements collectively suggest that the CRRT market, while competitive and complex, offers numerous avenues for growth through strategic innovation and adaptation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Renal Replacement Therapy Market

The Continuous Renal Replacement Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
    • Availability of improved CCRT systems for pediatric and neonatal patients
  • Market Restraints
    • High cost of continuous renal replacement therapy procedure
  • Market Opportunities
    • Ongoing research and development for enhanced safety and efficacy of CRRT
    • Favorable government approvals for CRRT machines and techniques
  • Market Challenges
    • Technical complications associated with continuous renal replacement therapy

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Renal Replacement Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Renal Replacement Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Renal Replacement Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Renal Replacement Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Renal Replacement Therapy Market

A detailed market share analysis in the Continuous Renal Replacement Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Renal Replacement Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Renal Replacement Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Joline GmbH & Co. KG, Infomed SA, Anjue Medical Equipment Co., Ltd., Medites Pharma spol. s.r.o, Baxter International Inc., SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, B. Braun SE, Medtronic PLC, Thermo Fisher Scientific Inc., Fresenius Medical Care AG & Co. KGaA, DIAMED Medizintechnik GmbH, Biomedica Medizinprodukte GmbH, Nextkidney B.V., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Ningbo Tianyi Medical Devices Co., Ltd., Braun & Co. Limited, Quanta Dialysis Technologies Limited, Miromatrix Medical Inc., Sphingotec GmbH, CytoSorbents Corporation, Toray Medical Co., Ltd. by Toray Industries, Inc., Nuwellis, Inc., SWS Hemodialysis Care Co. Ltd., and Nikkiso Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CRRT Systems, Dialysates & Replacement Fluids, and Disposables. The Disposables is further studied across Bodyline sets & tubes and Hemofilters.
  • Based on Modality, market is studied across Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemofiltration, and Slow Continuous Ultrafiltration.
  • Based on Age Group, market is studied across Adults and Pediatrics.
  • Based on Indication, market is studied across Non-renal and Renal.
  • Based on End User, market is studied across Dialysis Clinics, Homecare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
      • 5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of continuous renal replacement therapy procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
      • 5.1.3.2. Favorable government approvals for CRRT machines and techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
    • 5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
    • 5.2.3. Age Group: Differing CRRT requirements among pediatric population
    • 5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
    • 5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continuous Renal Replacement Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. CRRT Systems
  • 6.3. Dialysates & Replacement Fluids
  • 6.4. Disposables
    • 6.4.1. Bodyline sets & tubes
    • 6.4.2. Hemofilters

7. Continuous Renal Replacement Therapy Market, by Modality

  • 7.1. Introduction
  • 7.2. Continuous Venovenous Hemodiafiltration
  • 7.3. Continuous Venovenous Hemodialysis
  • 7.4. Continuous Venovenous Hemofiltration
  • 7.5. Slow Continuous Ultrafiltration

8. Continuous Renal Replacement Therapy Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Continuous Renal Replacement Therapy Market, by Indication

  • 9.1. Introduction
  • 9.2. Non-renal
  • 9.3. Renal

10. Continuous Renal Replacement Therapy Market, by End User

  • 10.1. Introduction
  • 10.2. Dialysis Clinics
  • 10.3. Homecare
  • 10.4. Hospitals

11. Americas Continuous Renal Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
    • 14.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
    • 14.3.3. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
    • 14.3.4. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
    • 14.3.5. Baxter, Miromatrix Partner on Liver Failure Research
    • 14.3.6. PBMC Launches New Renal Therapy Option for Dialysis Patients
    • 14.3.7. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
    • 14.3.8. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
    • 14.3.9. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

Companies Mentioned

  • 1. Joline GmbH & Co. KG
  • 2. Infomed SA
  • 3. Anjue Medical Equipment Co., Ltd.
  • 4. Medites Pharma spol. s.r.o
  • 5. Baxter International Inc.
  • 6. SB-KAWASUMI LABORATORIES, INC.
  • 7. Shionogi & Company, Limited
  • 8. B. Braun SE
  • 9. Medtronic PLC
  • 10. Thermo Fisher Scientific Inc.
  • 11. Fresenius Medical Care AG & Co. KGaA
  • 12. DIAMED Medizintechnik GmbH
  • 13. Biomedica Medizinprodukte GmbH
  • 14. Nextkidney B.V.
  • 15. Asahi Kasei Medical Co., Ltd.
  • 16. Nipro Corporation
  • 17. Ningbo Tianyi Medical Devices Co., Ltd.
  • 18. Braun & Co. Limited
  • 19. Quanta Dialysis Technologies Limited
  • 20. Miromatrix Medical Inc.
  • 21. Sphingotec GmbH
  • 22. CytoSorbents Corporation
  • 23. Toray Medical Co., Ltd. by Toray Industries, Inc.
  • 24. Nuwellis, Inc.
  • 25. SWS Hemodialysis Care Co. Ltd.
  • 26. Nikkiso Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023